RIO DE JANEIRO, BRAZIL - The decision of the European Medicines Agency (EMA) not to include Covishield, AstraZeneca's version of the vaccine manufactured in India, in a list of immunizers approved for its digital certificate for travelers, has caused doubts regarding the entry into the European Union of citizens from countries outside the block.
Brazil's Fiocruz received 4 million ready doses of Covishield among the 66 million doses of the AstraZeneca immunizer - which would expose citizens of Brazil to difficulties when traveling to Europe.
On Tuesday, June 29, when the agency announced the decision due to differences between Covishield . . .